NHC — National Healthcare Income Statement
0.000.00%
- $2.11bn
- $1.90bn
- $1.31bn
- 97
- 63
- 61
- 87
Annual income statement for National Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,028 | 1,074 | 1,086 | 1,142 | 1,307 |
| Cost of Revenue | |||||
| Gross Profit | 434 | 456 | 400 | 429 | 496 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 980 | 1,023 | 1,054 | 1,084 | 1,221 |
| Operating Profit | 48.2 | 50.9 | 31.9 | 57.1 | 86.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 52.4 | 150 | 27.2 | 88.7 | 136 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 42 | 139 | 20 | 65.3 | 102 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 41.9 | 139 | 22.4 | 66.8 | 102 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 41.9 | 139 | 22.4 | 66.8 | 102 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.21 | 10.8 | 0.732 | 4.34 | 6.19 |
| Dividends per Share |